XYNOMIC PHARMACEUTICALS HOLDINGS, INC.
CIK 0001697805
Revenue (TTM)
—
FY May 2020
Net Income (TTM)
−$24.59M
+12.2% YoY
FY May 2020
EPS Diluted (TTM)
—
FY May 2020
Gross Margin
—
FY May 2020
Operating Margin
—
FY May 2020
Net Margin
—
FY May 2020
Free Cash Flow (TTM)
−$10.72M
FY May 2020
Cash
$92.66K
FY May 2020
Total Debt
$78.95K
FY May 2020
Shares Outstanding
46.27M sh
FY May 2020
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.